Check in with UMC’s head of pharmacovigilance science to catch up with her team’s current research priorities.
Research / 09 April 2021
Causality is a tricky business in pharmacovigilance. With limited numbers of adverse event reports, how are we supposed to draw conclusions about causal relationships?
Research / 17 November 2020
Better understanding of genetic variation – between individuals and subpopulations – can inform more refined choices of drugs and doses. A new ISoP group is set to drive progress.
Research / 01 July 2020
Catch up with our research team and find out what's keeping a researcher intrigued right now.
Research / 10 April 2020
Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.